Kai-Yan Liu Selected Research

Hematologic Diseases (Blood Diseases)

1/2022	Donor CSF3R with the rs3917980A/G or G/G genotype is correlated with better leukemia-free survival after allogenic hematopoietic stem cell transplantation.
11/2020	Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidates.
10/2020	Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation.
1/2019	Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors.
2/2018	Predicted indirectly recognizable HLA epitopes are not associated with clinical outcomes after haploidentical hematopoietic stem cell transplantation.
3/2013	Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
12/2009	The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
8/2009	[Factors influencing engraftment in hematological patients after human leukocyte antigen matched sibling allogeneic blood and marrow transplantation].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kai-Yan Liu Research Topics

Disease

55	Leukemia 05/2022 - 04/2006
42	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2022 - 04/2007
37	Residual Neoplasm 10/2022 - 07/2008
30	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2008
27	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 01/2011
25	Infections 01/2022 - 12/2004
17	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2008
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2008
10	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2011
9	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2010
9	Philadelphia Chromosome 11/2021 - 01/2011
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2021 - 08/2008
9	Neoplasms (Cancer) 12/2020 - 04/2007
8	Hematologic Diseases (Blood Diseases) 01/2022 - 08/2009
7	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 12/2016
7	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 08/2008
5	Viremia 06/2021 - 01/2007
5	Multiple Myeloma 08/2020 - 02/2014
5	Hemorrhagic Cystitis 07/2018 - 01/2007
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2015
4	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 06/2007
3	Hemorrhage 01/2022 - 01/2007
3	Thrombotic Microangiopathies 01/2022 - 02/2018
3	Demyelinating Diseases (Demyelinating Disease) 11/2021 - 03/2013
3	Pneumonia (Pneumonitis) 10/2021 - 06/2009
3	Testicular Neoplasms (Testicular Cancer) 01/2020 - 02/2014
3	Acute Promyelocytic Leukemia 01/2019 - 05/2002
2	Anemia 12/2021 - 02/2014
2	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2021
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021 - 05/2012
2	Carcinogenesis 04/2021 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2014
2	Disease Progression 01/2021 - 02/2014
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2020 - 12/2015
2	Melanoma (Melanoma, Malignant) 01/2020 - 08/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 11/2017
1	Pancytopenia 01/2022
1	Proteinuria 12/2021
1	Epstein-Barr Virus Infections 11/2021

Drug/Important Bio-Agent (IBA)

17	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2008
9	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 02/2008
9	InterferonsIBA 01/2022 - 11/2015
6	Inosine Triphosphate (ITP)IBA 01/2022 - 12/2016
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 08/2008
6	AntigensIBA 01/2021 - 02/2014
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 05/2011
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2017
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
4	Immunoglobulin G (IgG)IBA 11/2021 - 07/2012
4	LigandsIBA 12/2019 - 04/2007
3	Prostaglandins FIBA 01/2022 - 10/2015
3	Tyrosine Kinase InhibitorsIBA 10/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2014
3	SteroidsIBA 01/2021 - 01/2019
3	Messenger RNA (mRNA)IBA 08/2020 - 10/2008
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2019 - 08/2017
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 03/2012
3	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2011
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2015 - 07/2008
3	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 07/2008
2	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2020
2	Basiliximab FDA Link 01/2022 - 01/2020
2	BilirubinIBA 01/2022 - 12/2021
2	Chimeric Antigen ReceptorsIBA 11/2021 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 06/2009
2	Aldehyde DehydrogenaseIBA 02/2021 - 09/2019
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021 - 06/2012
2	AntibodiesIBA 11/2020 - 01/2019
2	Methylprednisolone FDA LinkGeneric 01/2019 - 08/2011
2	Biological ProductsIBA 01/2019 - 05/2011
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 01/2018
2	GlucocorticoidsIBA 01/2019 - 07/2012
2	Busulfan (Busulfex)FDA Link 01/2018 - 08/2008
2	Pharmaceutical PreparationsIBA 11/2017 - 08/2011
2	C-Reactive ProteinIBA 02/2017 - 08/2016
2	Hemoglobins (Hemoglobin)IBA 10/2015 - 02/2014
2	EnzymesIBA 12/2009 - 05/2002
2	Immunosuppressive Agents (Immunosuppressants)IBA 07/2008 - 05/2008
2	Sulfides (Thioethers)IBA 06/2004 - 05/2002
2	ArsenicIBA 06/2004 - 05/2002
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Coffee FDA Link 01/2022
1	TeaIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Heme (Haem)IBA 12/2021
1	IronIBA 12/2021

Therapy/Procedure

130	Hematopoietic Stem Cell Transplantation 10/2022 - 01/2007
49	Transplantation 01/2022 - 12/2004
29	Therapeutics 09/2022 - 06/2004
27	Stem Cell Transplantation 01/2022 - 06/2012
18	Drug Therapy (Chemotherapy) 01/2020 - 02/2008
10	Haploidentical Transplantation 01/2021 - 11/2009
6	Cell Transplantation 12/2019 - 04/2006
5	Aftercare (After-Treatment) 02/2021 - 05/2011
4	Immunotherapy 05/2021 - 08/2016
4	Induction Chemotherapy 01/2021 - 01/2016
3	Consolidation Chemotherapy 03/2019 - 01/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017 - 02/2009
1	Plasma Exchange 01/2022